Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 38 Issue 1
Mar.  2020
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2020  >  38(1): 57-62

LU Jingrong, LIU Yawei, DAI Ying, LIN Houwen, YANG Fan. Study on the secondary metabolites from a polar marine sponge associated actinomyces Streptomyces sp. LHW11-07[J]. Journal of Pharmaceutical Practice and Service, 2022, 40(6): 499-504. doi: 10.12206/j.issn.2097-2024.202206081
Citation: MA Minghua, WANG Xiaohe, DAI Yuanyuan, GU Xiaoyan, WU Tiejun, NIAN Hua. Therapeutic effect of Xiakucao Xiaoliu mixture on Lewis lung cancer mice[J]. Journal of Pharmaceutical Practice and Service, 2020, 38(1): 57-62. doi: 10.3969/j.issn.1006-0111.201812070
shu

Therapeutic effect of Xiakucao Xiaoliu mixture on Lewis lung cancer mice

doi: 10.3969/j.issn.1006-0111.201812070
  • 1.

    Pharmaceutical Center of Yangpu District Central Hospital, Shanghai 200090, China

  • 2.

    Pharmaceutical Center of Yueyang Hospital, Shanghai University of TCM, Shanghai 200437, China

  • Received Date: 2018-12-24
  • Rev Recd Date: 2019-09-22
  • Objective To investigate the therapeutic effect of Xiakucao Xiaoliu mixture on Lewis lung cancer mice. Methods 30 mice with C57BL/6 mouse Lewis lung cancer xenograft model were randomly divided into three groups:model control group, Xiakucao Xiaoliu mixture group (M group), cisplatin group (DDP group). M group and DDP group were administered continuously for 14 days. Through the general observation of Lewis lung cancer mice, tumor size was determined, HE staining method was used to determine the histopathological changes of tumors, and the expression of CyclinD1 and P16 in tumor tissues was determined by immunohistochemistry. Results The tumor weight of the model control group was the heaviest, and the difference was statistically significant compared with other groups. (P<0.05). Survival state and quality of life of mice had been improved to some extent in M group. The results of tumor growth curve and HE staining in each group of mice showed that the growth of tumor cells had been inhibited and normal cells had been protected. The positive expression of CyclinD1 was significantly decreased in M group and DDP group (P<0.01), but the effect of M group on the improvement of P16 positive expression was not significant. Conclusion Xiakucao Xiaoliu mixture had a good effect on inhibiting lung tumor growth.
  • [1] TORRE L A, BRAY F, SIEGEL R L, et al. Global cancer statistics, 2012[J]. CA: Cancer J Clin,2015,65(2):87-108
    [2] 赵东杰. 中西医结合疗法对老年晚期非小细胞肺癌临床疗效的影响[J]. 中外医疗, 2017, 36(9):167-169
    [3] 王丽丽, 石磊, 钱祥, 等. 化疗联合清肺合剂改善非小细胞肺癌患者免疫功能的临床研究[J]. 中华全科医学, 2017, 15(7):1166-1168
    [4] 尚兴平, 齐敏. 益气养阴法联合化疗治疗晚期非小细胞肺癌的疗效观察[J]. 中国继续医学教育, 2017, 9(21):203-205
    [5] 柯军. 迷迭香酸抑制肺癌A549细胞的增殖及侵袭的实验研究[J]. 甘肃医药, 2015, 34(4):255-258
    [6] 贺天临, 谢国群, 陈洁, 等. 夏枯草消瘤合剂联合化疗治疗中晚期非小细胞肺癌30例[J]. 上海中医药大学学报, 2015, 29(5):29-32
    [7] 马雪曼, 于明薇, 张甘霖, 等. 小鼠Lewis肺癌不同部位皮下移植瘤模型的比较[J]. 中国实验动物学报, 2017, 25(4):386-390
    [8] 靳福鹏, 张梅, 李平, 等. 益气养阴解毒方对小鼠Lewis肺癌生长抑制作用的实验研究[J]. 临床肺科杂志, 2011, 16(1):72-74
    [9] 钱超尘, 温长路,赵怀舟,等(校). 金陵本《本草纲目》新校正[M]. 上海: 上海科学技术出版社, 2008.
    [10] 严东, 谢文剑, 李春, 等. 夏枯草化学成分及其体外抗肿瘤活性研究[J]. 中国实验方剂学杂志, 2016, 22(11):49-54
    [11] 张朝晖, 徐正顺, 焦龙华, 等. CyclinD1, P16, Rb蛋白在非小细胞肺癌组织中的表达[J]. 第四军医大学学报, 2003, 24(14):1271-1274
    [12] 王前, 邓晶, 蒋永新. CyclinD1的研究进展[J]. 现代肿瘤医学, 2009, 17(2):350-353
    [13] CHOI Y J, LI X Y, HYDBRING P, et al. The requirement for Cyclin D function in tumor maintenance[J]. Cancer Cell,2012,22(4):438-451
    [14] MASAMHA C P, BENBROOK D M. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of Cyclin E2 in ovarian cancer cells[J]. Cancer Res,2009,69(16):6565-6572
    [15] OGINO S, NOSHO K, IRAHARA N, et al. A cohort study of Cyclin D1 expression and prognosis in 602 colon cancer cases[J]. Clin Cancer Res,2009,15(13):4431-4438
    [16] ISHIKAWA T, FURIHATA M, OHTSUKI Y, et al. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma[J]. Br J Cancer,1998,77(1):92-97
    [17] LI H Y, XIAO W W, MA J W, et al. Dual high expression of STAT3 and CyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma[J]. Int J Clin Exp Pathol,2014,7(11):7989-7998
    [18] 夏靖华, 李维妙, 王雪娇, 等. CyclinD1与CyclinD3在非小细胞肺癌中的表达及意义[J]. 肿瘤学杂志, 2016, 22(8):615-621
    [19] 梁瑞韵, 廖增顺, 江山平, 等. CyclinD1和VEGF在非小细胞肺癌组织中的表达及其与预后的关系[J]. 癌症, 2003, 22(1):86-90
    [20] 付冉, 王艳林, 黄利鸣. p16表达异常与肿瘤关系的研究进展[J]. 生命的化学, 2017, 37(4):585-589
    [21] 冯蓓, 冯艳, 杨小平, 等. P16在肺癌方面的研究进展[J]. 延安大学学报(医学科学版), 2015, 13(1):70-73
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-0401234Highcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 94.5 %FULLTEXT: 94.5 %META: 4.1 %META: 4.1 %PDF: 1.4 %PDF: 1.4 %FULLTEXTMETAPDFHighcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 34.1 %其他: 34.1 %其他: 1.0 %其他: 1.0 %Austin: 0.2 %Austin: 0.2 %Brazil: 0.5 %Brazil: 0.5 %Bruderheim: 0.5 %Bruderheim: 0.5 %Canada: 1.2 %Canada: 1.2 %Canton: 0.5 %Canton: 0.5 %China: 0.2 %China: 0.2 %Egypt: 1.2 %Egypt: 1.2 %France: 0.7 %France: 0.7 %Gwynn Oak: 0.2 %Gwynn Oak: 0.2 %Indianapolis: 0.2 %Indianapolis: 0.2 %Italy: 0.2 %Italy: 0.2 %Joliet: 0.2 %Joliet: 0.2 %Lithonia: 0.2 %Lithonia: 0.2 %Malvern: 0.2 %Malvern: 0.2 %Norman: 0.5 %Norman: 0.5 %Palo Alto: 0.2 %Palo Alto: 0.2 %Poland: 0.5 %Poland: 0.5 %Rochester: 0.5 %Rochester: 0.5 %Russian Federation: 0.5 %Russian Federation: 0.5 %United Kingdom: 0.5 %United Kingdom: 0.5 %United States: 3.8 %United States: 3.8 %Westbury: 0.2 %Westbury: 0.2 %Wixom: 0.5 %Wixom: 0.5 %上海: 0.7 %上海: 0.7 %临汾: 0.2 %临汾: 0.2 %亨德森: 0.2 %亨德森: 0.2 %佛罗里达: 0.7 %佛罗里达: 0.7 %凤凰城: 0.2 %凤凰城: 0.2 %加利福尼亚州: 1.4 %加利福尼亚州: 1.4 %北京: 6.7 %北京: 6.7 %匹兹堡: 0.2 %匹兹堡: 0.2 %呼和浩特: 0.2 %呼和浩特: 0.2 %圣保罗: 0.2 %圣保罗: 0.2 %圣路易斯: 0.5 %圣路易斯: 0.5 %坦佩: 0.2 %坦佩: 0.2 %坦帕: 0.2 %坦帕: 0.2 %埃克塞特: 0.2 %埃克塞特: 0.2 %大急流城: 0.2 %大急流城: 0.2 %奥马哈: 0.5 %奥马哈: 0.5 %安德森: 0.2 %安德森: 0.2 %密蘇里城: 2.1 %密蘇里城: 2.1 %巴吞鲁日: 0.2 %巴吞鲁日: 0.2 %布劳利: 0.2 %布劳利: 0.2 %开罗: 0.7 %开罗: 0.7 %张家口: 0.5 %张家口: 0.5 %成都: 0.5 %成都: 0.5 %明尼阿波利斯: 0.2 %明尼阿波利斯: 0.2 %杰克逊维尔: 0.5 %杰克逊维尔: 0.5 %查尔斯顿: 0.2 %查尔斯顿: 0.2 %桑福德: 0.5 %桑福德: 0.5 %森尼韦尔: 1.7 %森尼韦尔: 1.7 %檀香山: 0.2 %檀香山: 0.2 %武汉: 0.5 %武汉: 0.5 %法拉盛: 0.2 %法拉盛: 0.2 %泽西: 0.2 %泽西: 0.2 %洛杉矶: 0.2 %洛杉矶: 0.2 %淮北: 0.2 %淮北: 0.2 %温莎: 0.2 %温莎: 0.2 %石家庄: 0.2 %石家庄: 0.2 %纽卡斯尔: 0.2 %纽卡斯尔: 0.2 %纽瓦克: 0.5 %纽瓦克: 0.5 %罗利: 0.2 %罗利: 0.2 %美国佛罗里达: 0.2 %美国佛罗里达: 0.2 %芒廷维尤: 10.5 %芒廷维尤: 10.5 %萨克拉门托: 0.2 %萨克拉门托: 0.2 %萨默维尔: 0.2 %萨默维尔: 0.2 %蒙特利尔: 0.2 %蒙特利尔: 0.2 %西宁: 11.9 %西宁: 11.9 %谢尔比: 0.2 %谢尔比: 0.2 %费利蒙: 0.2 %费利蒙: 0.2 %达曼: 0.5 %达曼: 0.5 %运城: 0.5 %运城: 0.5 %郑州: 0.2 %郑州: 0.2 %都伯林: 0.2 %都伯林: 0.2 %长春: 0.2 %长春: 0.2 %长治: 0.2 %长治: 0.2 %门尼菲: 0.5 %门尼菲: 0.5 %阳泉: 0.2 %阳泉: 0.2 %阿布奎基: 0.2 %阿布奎基: 0.2 %黄冈: 1.0 %黄冈: 1.0 %其他其他AustinBrazilBruderheimCanadaCantonChinaEgyptFranceGwynn OakIndianapolisItalyJolietLithoniaMalvernNormanPalo AltoPolandRochesterRussian FederationUnited KingdomUnited StatesWestburyWixom上海临汾亨德森佛罗里达凤凰城加利福尼亚州北京匹兹堡呼和浩特圣保罗圣路易斯坦佩坦帕埃克塞特大急流城奥马哈安德森密蘇里城巴吞鲁日布劳利开罗张家口成都明尼阿波利斯杰克逊维尔查尔斯顿桑福德森尼韦尔檀香山武汉法拉盛泽西洛杉矶淮北温莎石家庄纽卡斯尔纽瓦克罗利美国佛罗里达芒廷维尤萨克拉门托萨默维尔蒙特利尔西宁谢尔比费利蒙达曼运城郑州都伯林长春长治门尼菲阳泉阿布奎基黄冈Highcharts.com
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(5803) PDF downloads(3370) Cited by()

Related
Proportional views

Therapeutic effect of Xiakucao Xiaoliu mixture on Lewis lung cancer mice

doi: 10.3969/j.issn.1006-0111.201812070
  • 1. Pharmaceutical Center of Yangpu District Central Hospital, Shanghai 200090, China
  • 2. Pharmaceutical Center of Yueyang Hospital, Shanghai University of TCM, Shanghai 200437, China
  • Received Date: 2018-12-24
  • Rev Recd Date: 2019-09-22

Abstract: Objective To investigate the therapeutic effect of Xiakucao Xiaoliu mixture on Lewis lung cancer mice. Methods 30 mice with C57BL/6 mouse Lewis lung cancer xenograft model were randomly divided into three groups:model control group, Xiakucao Xiaoliu mixture group (M group), cisplatin group (DDP group). M group and DDP group were administered continuously for 14 days. Through the general observation of Lewis lung cancer mice, tumor size was determined, HE staining method was used to determine the histopathological changes of tumors, and the expression of CyclinD1 and P16 in tumor tissues was determined by immunohistochemistry. Results The tumor weight of the model control group was the heaviest, and the difference was statistically significant compared with other groups. (P<0.05). Survival state and quality of life of mice had been improved to some extent in M group. The results of tumor growth curve and HE staining in each group of mice showed that the growth of tumor cells had been inhibited and normal cells had been protected. The positive expression of CyclinD1 was significantly decreased in M group and DDP group (P<0.01), but the effect of M group on the improvement of P16 positive expression was not significant. Conclusion Xiakucao Xiaoliu mixture had a good effect on inhibiting lung tumor growth.

LU Jingrong, LIU Yawei, DAI Ying, LIN Houwen, YANG Fan. Study on the secondary metabolites from a polar marine sponge associated actinomyces Streptomyces sp. LHW11-07[J]. Journal of Pharmaceutical Practice and Service, 2022, 40(6): 499-504. doi: 10.12206/j.issn.2097-2024.202206081
Citation: MA Minghua, WANG Xiaohe, DAI Yuanyuan, GU Xiaoyan, WU Tiejun, NIAN Hua. Therapeutic effect of Xiakucao Xiaoliu mixture on Lewis lung cancer mice[J]. Journal of Pharmaceutical Practice and Service, 2020, 38(1): 57-62. doi: 10.3969/j.issn.1006-0111.201812070
shu

    HTML

Reference (21)

Catalog

  • HTML

版权所有：《药学实践与服务》编辑委员会

Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

网站备案号 沪ICP备05003363号-1

Supported by: Beijing Renhe Information Technology Co., Ltd.  

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return